masthead-publications

Categories

Filter by Topics

ABC-DLBCL Airway Remodeling AKT Targeted Therapy ALK Apoptosis AR-Specific T Cells Asthma Autocrine Signaling AXL B-cell lymphoma Biofluid Biomarker Biomarker Analysis Biomarker Discovery Biomarker Patient Stratification Biomarker Validation Biomarkers Outcome Biostats Bladder Cancer Immune Response Cardio Vascular Disease Cardiometabolic Traits CD44 Cells Cerebral Spinal Fluid Checkpoint Inhibitors Chemoresistance Chronic Obstructive Pulmonary Disease Circulating miRNAs Classification Clinical Trials Colon Colorectal cancer Comparison study Comprehensive Gene Expression Study Cord Blood Buffy Coat Core Needle Biopsy Custom mRNA Detection Diabetes Diagnostic Biomarkers Differential Diagnosis Differential Gene Expression Analysis Diffuse large B-cell lymphoma DLBCL Drug Response Drug Safety Drug Targets Drug-induced Liver Injury EGFR Muatations EMT EMT-mediated resistance Epigenetics Epigenomic Epstein-Barr Exosomes Fabry Disease Feasibility FFPE FFPE Canine Tumor FGF Ligand Trap Fibrous Tumors Gene Expression Analysis Gene Expression Profiling Gene Pathway Analysis Gene Signatures Genomic Genomic Bioinformatics Glioblastoma Tumors HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL Cell of Origin Assay EU HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA WTA HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System Human Hypoxia Immune Immune Related Genes Immune Tolerance Immuno-Oncology Immunofluorescence Immunology Immunotherapy Induction Chemotherapy Inflammation Interferon Gamma Signature Juvenile Arthritis Large B-cell Lymphoma Liquid Biopsy Liver Lung Lung Adenocarcinoma Lung cancer Lung Carcinoma Lymph Node Metastasis Lymphoma Mechanism of Action Mediation Hypothesis Melanoma Mesothelioma Metastatic Colon Cancer Methods Comparison Mice miRNA Molecular Characterization Mouse Mouse mRNA mRNA mRNA custom mRNA expression in tumors mTOR pathway mTORC1 mTORC2 Mucin Hypersecretion Muscle Mutations Myocardial Reperfusion NAFLD Nash and Fibrosis Neoantigens Neuroendocrine Tumor Nivolumab Non-small Cell Lung Cancer NSCLC Oncogenes Oncology Oncomirs Oral Cancer Oral Squamous Cell Carcinoma Osteoclast Ovarian cancer P13KmTOR Inhibitor Palbociclib Pancreas Pancreatic Cancer Pancreatic ductal adenocarcinoma Paralysis Pathogenesis Pathway Analysis Pathways PCA Cell Lines PD-1 PD-L1 PI3K signaling pathway Plasma Predictive Biomarkers Predictive Modeling Profiling Profiling Signature Development Prognostic prognostic Prognostic Biomarkers Programmed death ligand 1 Progression free-survival Prostate Prostate Cancer qNPA Regulation Renal Cell Carcinoma Response rate Reveal Risk Score Sarcoma SCBC SCLC Serum Signaling Inhibitors Signaling Pathways Signature Development Signature Validation Signatures Sinonasal Undifferentiated Carcinoma Small Cell Bladder Cancer Small Cell Lung Cancer SPECS Lung Consortium Squamous cell carcinoma Sub-typing Surveillance Survival Outcomes Synovial Fluid T cell T-cells Technology Comparison Therapeutic targets TMB Toxicity Translational Medicine Treatment Outcome Tumor Heterogeneity Urothelial carcinoma Uveal melanoma Vistusertib WNT Path Signaling Xenograft Tissue

2020

Prognostic Factors, Therapeutic Approaches, and Distinct Immunobiologic Features in Patients with Primary Mediastinal Large B-cell Lymphoma on Long-term Follow-up

Zhou H., et al. Prognostic Factors, Therapeutic Approaches, and Distinct Immunobiologic Features in Patients with Primary Mediastinal Large B-cell Lymphoma on Long-term Follow-up. Blood Cancer Journal (2020)10:49

Download pdf 1.0MB

Next Generation Sequencing and Functional Pathway Analysis to Understand the Mechanism of Action of Copper-Tolfenamic Acid Against Pancreatic Cancer.

Hurtado, M., et al. Next Generation Sequencing and Functional Pathway Analysis to Understand the Mechanism of Action of Copper-Tolfenamic Acid Against Pancreatic Cancer. Process Biochemistry 2020: 89: 155-164

View External Link

Pazopanib for Treatment of Typical Solitary Fibrous Tumours: A Multicentre, Single-arm, Phase 2 Trial

Broto, J. M., et al. Pazopanib for Treatment of Typical Solitary Fibrous Tumours: A Multicentre, Single-arm, Phase 2 Trial. The Lancet 2020;21(3),456-466. https://doi.org/10.1016/s1470-2045(19)30826-5

Download pdf 1.0MB
View External Link

Page last updated June 01, 2020